(BKUI) BNY Mellon Trust - BNY - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US09661T8595 • Ultrashort Bond

BKUI: Debt Securities, Cash Equivalents, Bonds, Notes, Commercial Paper

The BNY Mellon Ultra Short Income ETF (BKUI) is an exchange-traded fund designed to provide exposure to short-duration, high-quality fixed-income securities. The fund primarily invests in U.S. dollar-denominated, investment-grade debt instruments, including fixed-, variable-, and floating-rate securities, as well as cash equivalents. At least 80% of its net assets are allocated to these types of securities. The funds portfolio is constructed to maintain an effective duration of one year or less under normal market conditions, though this duration may extend during periods of heightened interest rate or credit spread volatility.

The ETFs holdings typically carry an average credit rating of A or equivalent, reflecting the funds focus on conservative, low-risk investments. This approach aims to mitigate exposure to credit risk while providing liquidity and stability in varying market environments. The fund is managed by BNY Mellon, a well-established financial institution with expertise in fixed-income strategies.

As of the latest data, the fund has approximately $206.42 million in assets under management (AUM), with an average daily trading volume of 18,073 shares. Its current price is $49.69, with short-term technical indicators suggesting a stable trend. The 20-day simple moving average (SMA) stands at $49.70, slightly above the current price, while the 50-day SMA is at $49.54, indicating mild upward momentum. The 200-day SMA, at $48.77, reflects longer-term strength. The average true range (ATR) of 0.03 highlights the funds low volatility.

Over the next three months, based on current technical and fundamental trends, the fund is expected to maintain its stable performance. The short-term moving averages suggest a slight upward bias, though the low ATR indicates minimal price movement. The funds AUM remains steady, signaling investor confidence in its strategy. Given its focus on high-quality, short-duration securities, BKUI is likely to continue providing a low-risk investment option with modest returns, making it suitable for investors seeking liquidity and capital preservation in a rising interest rate environment.

Additional Sources for BKUI ETF

BKUI ETF Overview

Market Cap in USD 206m
Category Ultrashort Bond
TER 0.12%
IPO / Inception 2021-08-09

BKUI ETF Ratings

Growth 5y 64.2%
Fundamental -
Dividend 71.3%
Rel. Strength Industry 7.05
Analysts -
Fair Price Momentum 48.41 USD
Fair Price DCF -

BKUI Dividends

Dividend Yield 12m 4.72%
Yield on Cost 5y 5.24%
Annual Growth 5y 120.64%
Payout Consistency 80.0%

BKUI Growth Ratios

Growth Correlation 3m 99.8%
Growth Correlation 12m 100%
Growth Correlation 5y 89.6%
CAGR 5y 3.29%
CAGR/Max DD 5y 1.91
Sharpe Ratio 12m 1.90
Alpha 1.37
Beta 0.00
Volatility 0.60%
Current Volume 24.3k
Average Volume 20d 13.2k
What is the price of BKUI stocks?
As of March 13, 2025, the stock is trading at USD 49.72 with a total of 24,309 shares traded.
Over the past week, the price has changed by +0.04%, over one month by +0.51%, over three months by +1.28% and over the past year by +5.59%.
Is BNY Mellon Trust - BNY a good stock to buy?
Yes. Based on ValueRay Analyses, BNY Mellon Trust - BNY (NYSE ARCA:BKUI) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 64.23 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKUI as of March 2025 is 48.41. This means that BKUI is currently overvalued and has a potential downside of -2.63%.
Is BKUI a buy, sell or hold?
BNY Mellon Trust - BNY has no consensus analysts rating.
What are the forecast for BKUI stock price target?
According to ValueRays Forecast Model, BKUI BNY Mellon Trust - BNY will be worth about 52.3 in March 2026. The stock is currently trading at 49.72. This means that the stock has a potential upside of +5.15%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 52.3 5.1%